Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery

[1]  M. Okada,et al.  Thoracic and cardiovascular surgeries in Japan during 2019 , 2023, General Thoracic and Cardiovascular Surgery.

[2]  E. Bastiaannet,et al.  Physical Function and Physical Activity in Older Breast Cancer Survivors: 5-Year Follow-Up from the Climb Every Mountain Study , 2023, The oncologist.

[3]  N. Altorki,et al.  Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. , 2023, The New England journal of medicine.

[4]  J. Buckner,et al.  Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. , 2022, JAMA oncology.

[5]  M. Galsky,et al.  Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study , 2022, Annals of Oncology.

[6]  O. Nanni,et al.  Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study , 2022, Journal of the National Cancer Institute.

[7]  Kenji Suzuki,et al.  Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial , 2022, The Lancet.

[8]  V. Puri,et al.  Long-term patient-reported outcomes after non-small cell lung cancer resection. , 2022, The Journal of thoracic and cardiovascular surgery.

[9]  E. Wulff-Burchfield,et al.  Functional Status and Survival in Older Nursing Home Residents With Advanced Non–Small-Cell Lung Cancer: A SEER-Medicare Analysis , 2022, JCO oncology practice.

[10]  G. Sánchez-Benavides,et al.  Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Simonsick,et al.  Functional decline among older cancer survivors in the Baltimore longitudinal study of aging , 2021, Journal of the American Geriatrics Society.

[12]  A. Shahrokni,et al.  Surgical Considerations for Older Adults With Cancer: A Multidimensional, Multiphase Pathway to Improve Care. , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  H. Cohen,et al.  From Assessment to Implementation and Beyond in Cancer and Aging Research. , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  B. Haas,et al.  All-Cause and Cancer-Specific Death of Older Adults Following Surgery for Cancer. , 2021, JAMA surgery.

[15]  N. Taira,et al.  Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Kenji Suzuki,et al.  A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707) , 2020, JTCVS open.

[17]  Lisa Brown,et al.  Health-Related Quality of Life after Lobectomy for Lung Cancer: Conceptual Framework and Measurement. , 2020, The Annals of thoracic surgery.

[18]  G. Abel,et al.  Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  F. Barlesi,et al.  Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). , 2018, Lung cancer.

[20]  M. Okada,et al.  A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303 , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  L. Gaspar,et al.  Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Gan,et al.  Changes in the use of end points in clinical trials for elderly cancer patients over time , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  M. Litwin,et al.  Burden of Geriatric Events Among Older Adults Undergoing Major Cancer Surgery. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Daurès,et al.  Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Volker W Stieber,et al.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. , 2016, JAMA.

[26]  S. Ikeda,et al.  Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D , 2015, Quality of Life Research.

[27]  P. Kind,et al.  Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Takashi Fukuda,et al.  Developing a Japanese version of the EQ-5D-5L value set , 2015 .

[29]  H. Cohen,et al.  Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Murielle Mauer,et al.  End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  B. V. van Munster,et al.  Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. , 2012, The Lancet. Oncology.

[32]  C. Wolfson,et al.  Changes in functional status in older newly-diagnosed cancer patients during cancer treatment: A six-month follow-up period. Results of a prospective pilot study , 2011 .

[33]  E. Miyaoka,et al.  Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[34]  R. Hays,et al.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.

[35]  N. Ikegami,et al.  Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.

[36]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[37]  H. Shibata,et al.  [Functional capacity of the elderly: measurement by the TMIG Index of Competence]. , 1993, [Nihon koshu eisei zasshi] Japanese journal of public health.

[38]  K. Nakazato,et al.  Measurement of competence: reliability and validity of the TMIG Index of Competence. , 1991, Archives of gerontology and geriatrics.

[39]  H. Wildiers,et al.  Performance of two geriatric screening tools in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Christine Schuon.  About this Study , 2021, Doors, Entrances and Beyond... Various Aspects of Entrances and Doors of the Tombs in the Memphite Necropoleis during the Old Kingdom.

[41]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.